Prognostic significance of galectin‐3 expression in patients with resected NSCLC treated with platinum‐based adjuvant chemotherapy

BACKGROUND: Galectin‐3 (GAL3), a protein encoded by the LGALS3 gene, plays diverse roles in cancer initiation, progression, and drug resistance. Accordingly, high GAL3 expression in tumor cells is associated with poor prognosis in non‐small cell lung cancer (NSCLC). However, the prognostic impact of...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Thorac Cancer
Päätekijät: Kusuhara, Seiichiro, Igawa, Satoshi, Ichinoe, Masaaki, Nagashio, Ryo, Kuchitsu, Yuki, Hiyoshi, Yasuhiro, Shiomi, Kazu, Murakumo, Yoshiki, Saegusa, Makoto, Satoh, Yukitoshi, Sato, Yuichi, Naoki, Katsuhiko
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley & Sons Australia, Ltd 2021
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8107024/
https://ncbi.nlm.nih.gov/pubmed/33793071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13945
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia